ChLpMab-23: Cancer-Specific Human–Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity
Mika K. Kaneko(Tohoku University), Yukinari Kato(Tohoku University), Shinji Yamada(Tohoku University), Takuro Nakamura(Tokyo Medical University), Yasuhiko Nishioka(Tokushima University), Noriko Saidoh(Tohoku University), Akiko Kunita(Bunkyo University), Satoshi Ogasawara(Kyoto University), Yuki Fujii(Hokkaido University of Science), Shinji Abe(Tokushima University), Miyuki Yanaka(Tohoku University), Kanae Yoshida(Tohoku University), Masashi Fukayama(The University of Tokyo)
Cited by 56
Related Papers
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
An approach to position sensorless drive for brushless DC motors
|IEEE Transactions on Industry Applications|1991|448
An active circuit for cancellation of common-mode voltage generated by a PWM inverter
|IEEE Transactions on Power Electronics|1998|393
Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents
|Cell Reports|2018|369